Fig. 1 · Structure
Documents & Downloads
Tenilsetam
Antidementia Compound
Tenilsetam is an antidementia compound that acts as an advanced glycation end product (AGE) inhibitor. It has demonstrated potential in inhibiting early retinopathy in experimental diabetes models, suggesting a protective role against neurodegeneration. This compound is valuable for research into therapeutic strategies targeting cognitive decline associated with diabetes and other neurodegenerative disorders.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 86696-86-8 |
| Applications | Antidementia Compound |
| Formula | C8H10N2OS |
| Molecular Weight | 182.24 |
| Synonyms | CAS 997 |
| SMILES | O=C1NCCNC1C2=CC=CS2 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.